Candriam SCA’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $167M | Sell |
|
|||||
|
2025
Q1 | $176M | Sell |
|
|||||
|
2024
Q4 | $159M | Sell |
|
|||||
|
2024
Q3 | $175M | Buy |
|
|||||
|
2024
Q2 | $139M | Sell |
|
|||||
|
2024
Q1 | $167M | Buy |
|
|||||
|
2023
Q4 | $181M | Buy |
|
|||||
|
2023
Q3 | $113M | Sell |
|
|||||
|
2023
Q2 | $130M | Buy |
|
|||||
|
2023
Q1 | $128M | Buy |
|
|||||
|
2022
Q4 | $140M | Sell |
|
|||||
|
2022
Q3 | $124M | Sell |
|
|||||
|
2022
Q2 | $125M | Buy |
|
|||||
|
2022
Q1 | $104M | Buy |
|
|||||
|
2021
Q4 | $115M | Buy |
|
|||||
|
2021
Q3 | $109M | Sell |
|
|||||
|
2021
Q2 | $110M | Sell |
|
|||||
|
2021
Q1 | $123M | Sell |
|
|||||
|
2020
Q4 | $128M | Buy |
|
|||||
|
2020
Q3 | $122M | Buy |
|
|||||
|
2020
Q2 | $130M | Sell |
|
|||||
|
2020
Q1 | $143M | Buy |
|
|||||
|
2019
Q4 | $147M | Buy |
|
|||||
|
2019
Q3 | $142M | Buy |
|
|||||
|
2019
Q2 | $134M | Sell |
|
|||||
|
2019
Q1 | $131M | Buy |
|
|||||
|
2018
Q4 | $98.4M | Buy |
|
|||||
|
2018
Q3 | $103M | Buy |
|
|||||
|
2018
Q2 | $63.9M | Buy |
|
|||||
|
2018
Q1 | $57.7M | Sell |
|
|||||
|
2017
Q4 | $56.4M | Sell |
|
|||||
|
2017
Q3 | $92.1M | Sell |
|
|||||
|
2017
Q2 | $101M | Sell |
|
|||||
|
2017
Q1 | $103M | Buy |
|
|||||
|
2016
Q4 | $67.2M | Buy |
|
|||||
|
2016
Q3 | $66.6M | Sell |
|
|||||
|
2016
Q2 | $76.3M | Sell |
|
|||||
|
2016
Q1 | $108M | Buy |
|
|||||
|
2015
Q4 | $118M | Buy |
|
|||||
|
2015
Q3 | $114M | Buy |
|
|||||
|
2015
Q2 | $126M | Buy |
|
|||||
|
2015
Q1 | $93.5M | Buy |
|
|||||
|
2014
Q4 | $83.7M | Buy |
|